SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Duramed (DRMD) Synthetic Estrogen Product

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: vestor who wrote (1448)10/18/1999 6:54:00 PM
From: Doug Bean  Read Replies (1) of 1837
 
VESTOR:
And really we should get a rapid acceleration after the bone marker study.
We all know it will come in very positive because after all cenestin is really the same as Premarin without the delta 8/9 impurities.
Anyway like my wifes doctor many doctors are okay with it if it helps prevent bone loss.
As soon as its written up in a acceptable journal her doctor says its okay to switch. for now he is against it but only the bone study is betwen approval and rejection.
1% is a goal then 5% then 10% and so on ... We have our own markers to watch and it wil be fun to see the momentum build.
CRDoug
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext